---
title: "3 Best Healthcare Stocks to Buy in May 2026, According to Analysts"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/286619134.md"
description: "Healthcare stocks are back in focus this month as investors look for strong pipelines and steady growth in a market still driven by AI and biotech innovation. Analysts say three names stand out in May 2026 for their long-term upside: Legend Biotech (LEGN), Crinetics Pharmaceuticals (CRNX), and Nektar Therapeutics (NKTR).Claim 55% Off TipRanksUnlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks"
datetime: "2026-05-15T21:28:05.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/286619134.md)
  - [en](https://longbridge.com/en/news/286619134.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/286619134.md)
---

# 3 Best Healthcare Stocks to Buy in May 2026, According to Analysts

Healthcare stocks are back in focus this month as investors look for strong pipelines and steady growth in a market still driven by AI and biotech innovation. Analysts say three names stand out in May 2026 for their long-term upside: Legend Biotech (LEGN), Crinetics Pharmaceuticals (CRNX), and Nektar Therapeutics (NKTR).

### Claim 55% Off TipRanks

-   Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
-   Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks

### Related Stocks

- [CRNX.US](https://longbridge.com/en/quote/CRNX.US.md)
- [LEGN.US](https://longbridge.com/en/quote/LEGN.US.md)
- [NKTR.US](https://longbridge.com/en/quote/NKTR.US.md)
- [ARKG.US](https://longbridge.com/en/quote/ARKG.US.md)
- [IBBQ.US](https://longbridge.com/en/quote/IBBQ.US.md)
- [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md)
- [BIB.US](https://longbridge.com/en/quote/BIB.US.md)
- [LABU.US](https://longbridge.com/en/quote/LABU.US.md)
- [IXJ.US](https://longbridge.com/en/quote/IXJ.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [VHT.US](https://longbridge.com/en/quote/VHT.US.md)
- [XLV.US](https://longbridge.com/en/quote/XLV.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)
- [IHE.US](https://longbridge.com/en/quote/IHE.US.md)

## Related News & Research

- [Barclays Reaffirms Their Buy Rating on Legend Biotech (LEGN)](https://longbridge.com/en/news/286227290.md)
- [These Analysts Revise Their Forecasts On Legend Biotech After Q1 Results](https://longbridge.com/en/news/286301750.md)
- [LifeSci Capital Sticks to Their Buy Rating for Tenax Therapeutics (TENX)](https://longbridge.com/en/news/286648286.md)
- [Roth MKM Sticks to Their Buy Rating for Capricor Therapeutics (CAPR)](https://longbridge.com/en/news/286497683.md)
- [Lantern Pharma raises capital, plans AI platform spinoff](https://longbridge.com/en/news/286480334.md)